You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE

Chronic Fatigue Syndrome: The Challenges in Primary Care

  • Authors: Anthony L. Komaroff, MD; Charles W. Lapp, MD; Lucinda Bateman, MD
  • CME/CE Released: 3/23/2012
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 3/23/2013
Start Activity


Target Audience and Goal Statement

This activity is intended for primary care providers who diagnose and/or manage patients with CFS.

The goal of this activity is to raise awareness about CFS and educate clinicians about diagnosing and managing CFS.

Upon completion of this activity, participants will be able to:

  1. Identify CFS utilizing the 1994 International Case Definition, and diagnose CFS using this definition and other clinical tools including physical and laboratory examinations
  2. Demonstrate the ability to treat and manage CFS on an individual basis
  3. Recognize the wide-ranging impact of CFS


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Authors

  • Anthony L. Komaroff, MD

    Simcox-Clifford-Higby Professor of Medicine, Harvard Medical School; Senior Physician, Brigham Women’s Medical Hospital, Boston, Massachusetts

    Disclosures

    Disclosure: Anthony L. Komaroff, MD, has disclosed no relevant financial relationships.

    Dr Komaroff does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Komaroff does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Charles W. Lapp, MD

    Director, Hunter-Hopkins Center; Associate Consulting Professor, Duke University Medical Center, Charlotte, North Carolina

    Disclosures

    Disclosure: Charles W. Lapp, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Pfizer Inc.
    Served as a speaker or a member of a speakers bureau for: Eli Lilly and Company; Forest Laboratories, Inc; Pfizer Inc. Owns stock, stocks option, or bonds from: Hemispherx Biopharma, Inc.

    Dr Lapp does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Lapp does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Lucinda Bateman, MD

    Director, Fatigue Consultation Clinic; Co-founder and Executive Director; Organization for Fatigue and Fibromyalgia Education and Research; Salt Lake City, Utah

    Disclosures

    Disclosure: Lucinda Bateman, MD, has disclosed the following relevant financial relationships: Served as an advisor or consultant for: Pfizer Inc.
    Served as a speaker or a member of a speakers bureau for: Eli Lilly and Company; Forest Laboratories, Inc; Pfizer Inc.
    Received grants for clinical research from: Pfizer Inc.
    Served as the principal investigator for phase III drug trials for: Eli Lilly and Company; Forest Laboratories, Inc.; Hemispherx Biopharma, Inc; Pfizer Inc.

    Dr Bateman does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Bateman does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

  • Shari Weisenfeld, MD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Shari Weisenfeld, MD, has disclosed no relevant financial relationships.

  • Kristen L. Dascoli

    Clinical Editor, Medscape, LLC

    Disclosures

    Disclosure: Kristen L. Dascoli has disclosed no relevant financial relationships.

CME Reviewer

  • Nafeez Zawahir, MD

    CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Nurse Planner

  • Laurie E. Scudder, DNP, NP

    Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

    Disclosures

    Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape Education encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME/CE

Chronic Fatigue Syndrome: The Challenges in Primary Care

Authors: Anthony L. Komaroff, MD; Charles W. Lapp, MD; Lucinda Bateman, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME/CE Released: 3/23/2012

Valid for credit through: 3/23/2013

processing....

  • Print